secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2024-07-19T23:59:59+00:00
Accession:  0001213900-24-062766
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longeveron raises $9.0M via registered direct offering of 2.24M shares at $4.025; warrants at $3.90
--------------------------------------------------------------------------------

- Gross proceeds of approximately $9.0M from sale of 2,236,026 shares and concurrent private placement of warrants for 2,236,026 shares.
- Warrants exercisable immediately at $3.90 per share for 24 months; placement agent fees of 7% plus warrants at $5.0313.
- Net proceeds to fund Lomecel-B clinical programs for HLHS and Alzheimer's disease, regulatory approvals, and working capital.
- Closing expected on July 19, 2024; H.C. Wainwright acted as exclusive placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000121390024062766/0001213900-24-062766-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000121390024062766/ea0209682-8k_longe.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-062766

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer